StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UPDATE: Bernstein Downgrades Biogen (BIIB) to Market Perform
October 19, 2018 6:08 AM
(Updated - October 19, 2018 7:40 AM EDT)
(updated to add analyst name, price target and comment)Bernstein analyst Aaron ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Hot Downgrades
Next Articles
Biogen (BIIB), UCB Report Topline Results from Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
October 23, 2018 5:42 AM